Aluise, C., Miriyala, S., Noel, T., Sultana, R., Jungsuwadee, P., Taylor, T., … Butterfield, D. (2011). 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: implications for the reactive oxygen species-mediated mechanisms of chemobrain. Free Radical Biology & Medicine, 50(11), 1630-8. https://doi.org/10.1016/j.freeradbiomed.2011.03.009 (Original work published 2011)

Jungsuwadee, P., Zhao, T., Stolarczyk, E., Paumi, C., Butterfield, D., St Clair, D., & Vore, M. (2012). The G671V variant of MRP1/ABCC1 links doxorubicin-induced acute cardiac toxicity to disposition of the glutathione conjugate of 4-hydroxy-2-trans-nonenal. Pharmacogenetics and Genomics, 22(4), 273-84. https://doi.org/10.1097/FPC.0b013e328350e270

Jungsuwadee, P., Nithipongvanitch, R., Chen, Y., Oberley, T., Butterfield, D., St Clair, D., & Vore, M. (2009). Mrp1 localization and function in cardiac mitochondria after doxorubicin. Molecular Pharmacology, 75(5), 1117-26. https://doi.org/10.1124/mol.108.052209

Chen, Y., Jungsuwadee, P., Vore, M., Butterfield, D., & St Clair, D. (2007). Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues. Molecular Interventions, 7(3), 147-56. https://doi.org/10.1124/mi.7.3.6

Jungsuwadee, P., Cole, M., Sultana, R., Joshi, G., Tangpong, J., Butterfield, D., … Vore, M. (2006). Increase in Mrp1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of Adriamycin-treated C57BL/6 mice. Molecular Cancer Therapeutics, 5(11), 2851-60. https://doi.org/10.1158/1535-7163.MCT-06-0297

Thomas, T., Beitchman, J., Pomerleau, F., Noel, T., Jungsuwadee, P., Butterfield, D., … Gerhardt, G. (2017). Acute treatment with doxorubicin affects glutamate neurotransmission in the mouse frontal cortex and hippocampus. Brain Research, 1672, 10-17. https://doi.org/10.1016/j.brainres.2017.07.003 (Original work published 2017)